“Long-Term Evaluation of Infliximab in the Treatment of Persistently Active Juvenile Idiopathic Arthritis Refractory to Conventional Therapy”. Reumatismo 59, no. 1 (March 30, 2007): 50–56. Accessed July 4, 2025. https://www.reumatismo.org/reuma/article/view/reumatismo.2007.50.